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ABSTRACT
Repair of single-stranded DNA breaks before
DNA replication is critical in maintaining genomic
stability; however, how cells deal with these lesions
during S phase is not clear. Using combined
approaches of proteomics and in vitro and in vivo
protein–protein interaction, we identified the p58
subunit of DNA Pol a-primase as a new binding part-
ner of XRCC1, a key protein of the single strand
break repair (SSBR) complex. In vitro experiments
reveal that the binding of poly(ADP-ribose) to
p58 inhibits primase activity by competition with
its DNA binding property. Overexpression of
the XRCC1-BRCT1 domain in HeLa cells induces
poly(ADP-ribose) synthesis, PARP-1 and XRCC1-
BRCT1 poly(ADP-ribosyl)ation and a strong S
phase delay in the presence of DNA damage.
Addition of recombinant XRCC1-BRCT1 to
Xenopus egg extracts slows down DNA synthesis
and inhibits the binding of PCNA, but not MCM2 to
alkylated chromatin, thus indicating interference
with the assembly of functional replication forks.
Altogether these results suggest a critical role for
XRCC1 in connecting the SSBR machinery with the
replication fork to halt DNA synthesis in response to
DNA damage.
INTRODUCTION
The cellular response to DNA damage produced by envi-
ronmental agents or generated by the cellular metabolism
involves the coordinated activation of various enzymatic
activities aimed at detecting, signaling and resolving faith-
fully genomic discontinuities. XRCC1 plays a crucial role
in the coordination of two overlapping repair pathways,
base excision repair (BER) and single strand break repair
(SSBR), through the association with and stimulation of
several key enzymes involved at diﬀerent steps of these
pathways [reviewed in (1,2)]. The two BRCT domains
(BRCT1, from amino acids 314 to 403; and BRCT2,
from amino acids 538 to 633) of XRCC1 mediate a net-
work of protein–protein interactions with these repair fac-
tors. The BRCT1 domain is the most evolutionarily
conserved and is required for survival after methylation
damage (3,4). It interacts with PARP-1 and PARP-2, and
contains a binding site for poly (ADP-ribose) (PAR) med-
iating the rapid recruitment of XRCC1 at the site of DNA
damage (5–9). The BRCT2 domain of XRCC1 binds to
and stabilizes DNA ligase III (Lig III) (10).
Several observations suggest that the hypersensitivity of
XRCC1-mutant cell lines to monofunctional alkylating
agents results from the persistence of unrepaired single
strand breaks (SSBs) that are encountered by the DNA
replication fork during S phase. The XRCC1 deﬁcient
EM9 cell line exhibits an increased doubling time and an
elevated level of sister-chromatid exchange (SCE) (11,12).
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BRCT1 domain of XRCC1 is defective in the restart of
DNA replication following methyl-methane sulfonate
(MMS) treatment, while this mutant is proﬁcient in
DNA repair. Recently, Lan et al. (13) showed that sup-
pressing XRCC1 expression by RNA interference
decreased PCNA accumulation on SSBs induced by
laser irradiation and Fan et al. (14) reported a direct inter-
action between XRCC1 and PCNA in vitro and in vivo in
S phase. Altogether, these results further extended a possi-
ble link between the SSBR machinery and the replicative
apparatus.
The formation of functional DNA replication forks
occurs by the sequential assembly of large multiprotein
complexes at DNA replication origins [reviewed in
(15,16)]. The origin recognition complex (ORC1-6)
together with the Cdc6 and Cdt1 proteins, catalyze the
formation of pre-replicative complexes (pre-RCs),
namely the assembly of the MCM2-7 helicase complex.
Activation of pre-RCs during S phase allows the recruit-
ment of additional replication factors to form pre-
initiation complexes (pre-ICs) that can support DNA
unwinding and recruit the DNA polymerases and other
factors required to promote DNA synthesis. To begin
DNA synthesis, an initial RNA primer is synthesized by
the DNA primase, a heterodimer of two subunits, p48 and
p58. This short RNA primer is then extended by DNA Pol
a and marks the formation of initiation complexes (ICs).
Then replication factor C (RFC) binds to the primer tem-
plate junction and catalyzes the loading of the ring-shaped
replication factor PCNA that encircles DNA and associ-
ates with the replicative polymerases Pol d or -e, taking
over DNA synthesis from Pol a (elongation step).
Here, we show that the BRCT1 domain of XRCC1 spe-
ciﬁcally interacts in vitro and in vivo with the p58 subunit
of DNA Pol a-primase in HeLa cells. p58 also interacts
with PAR resulting in the inhibition of the p48–p58
primase activity in vitro. Consistent with these ﬁndings,
the expression of the BRCT1 domain of XRCC1 in
HeLa cells or in Xenopus extracts interferes with ongoing
DNA synthesis in the presence of DNA damage in a PAR-
dependent manner. These results suggest that the BRCT1
domain of XRCC1 plays a central role in regulating DNA
replication across SSBs during S phase.
MATERIALS AND METHODS
Constructionof XRCC1 and p58 expression vectors
From the human DNA primase p48-His-tagged-p58 and
p58C-terminus cloned in pET11 (17), we ampliﬁed the
DNA sequence encoding p58 by PCR (amino acids
1–266) and cloned it in the NdeI and BamHI restriction
sites of the pET 15b vector (Novagen).
Vectors allowing the expression in mammalian cells
of GST-tagged fragments of human hXRCC1 are
described in (18). PCR ampliﬁed fragment encoding
Xenopus xXRCC1-BRCT1 (amino acids 307–414) was
subcloned into the EcoRI and XhoI of pGEX 4T vector
allowing overproduction of the GST fused proteins in
Escherichia coli.
Antibodies
The following antibodies were used: rat monoclonal
anti-p58 antibody (19), mouse monoclonal anti-GST anti-
body (kindly given by M. Oulad, IGBMC, Illkirch), rabbit
polyclonal anti-RPA antibody (D. Maiorano, IGH,
Montpellier), rabbit polyclonal anti-ORC1 antibody
(20), rabbit polyclonal anti-MCM2 antibody (AbCam),
mouse monoclonal anti-PARP-1 (EGT69), rabbit polyclo-
nal anti-GST, mouse monoclonal anti-PCNA antibody
(PC10, Sigma-Aldrich), goat polyclonal anti-XRCC1 anti-
body (D-18 sc-5902, Santa Cruz Biotechnology Inc.),
rabbit polyclonal anti-XRCC1 (Alexis), rabbit polyclonal
anti-PAR, and mouse monoclonal anti-BrdU antibodies
(Becton Dickinson and Company), and rabbit polyclonal
anti-phospho Chk1 (S345) antibody (Cell Signalling).
Secondary antibodies, from Molecular Probes, are either
goat anti-mouse, donkey anti rat or goat anti-rabbit
antibodies, peroxidase-conjugated or alexa 488/alexa
568-conjugated.
Protein expression, purification, GST pull-down assays
and immunoprecipitation
Fusion proteins were expressed in E. coli (BRCT1: amino
acids 282–428 or BRCT2: 538–633 domains) and puriﬁed
using the aﬃnity of either GST for glutathione-coupled
beads (GE Healthcare, Amersham Biosciences) or His-
tag for Ni
2+ ions immobilized on a silica-based resin
(Protino
R Ni, Machery-Nagel) as recommended by
manufacturers.
GST pull-down and immunoprecipitation experiments
were carried as described in (18). When indicated, cells
were treated with aphidicolin (A, 5mg/ml for 16h)
followed or not by hydroxyurea treatment (HU, 4mM
for 4h) or by MMS (2.5mM for 30min) with or without
PARP [Poly (ADP-ribose) Polymerase] inhibitor
(Ku-0058948, 100nM).
Immunofluorescence
Cells (10
5) grown on glass cover slips, in DMEM medium
containing 10% fetal bovine serum and 0.5% gentamicin
were treated or not with HU (4mM for 4h at 378C) and
processed further as described in (18).
Mass spectrometry
GST or GST-hXRCC1-BRCT1 (amino acids 282–428)
produced in E. coli, ﬁxed on glutathione-coupled beads
were used to purify interacting proteins from HeLa cell
extracts (18). Proteins were separated on SDS–Poly
Acylamide Gel Electrophoresis (PAGE) gel, stained with
SYPRO-ruby and gel slices containing protein bands of
interest were excised and processed for mass spectrometry.
In-gel digestion was performed with an automated protein
digestion system, MassPREP Station (Waters, Milford,
MA, USA). The resulting peptide extracts were directly
injected for nanoscale capillary LC-MS/MS (nano-LC-
MS/MS) analysis (21). Mass data acquisitions were
piloted by MassLynx software (Waters) using automatic
switching between MS and MS/MS modes as described
previously (22).
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Proteins were separated by SDS–PAGE (2mg) or dot-
blotted directly on membrane (1 or 2mg, as indicated).
Polyacrylamide gels were incubated for 1h at room tem-
perature in a 50mM Tris pH 8, 30% glycerol buﬀer, and
proteins were transferred on nitrocellulose membranes
for PAR and DNA binding or on Polyvinylidene
Fluoride (PVDF) membranes for far-western blotting.
Proteins were then re-naturated overnight at 48Ci na
50mM Tris pH 8, 150mM NaCl, 5mM MgCl2,1 m M
DTT, 1mM EDTA, 0.3% Tween 20 and 5% non-fat
dried milk buﬀer. In vitro PAR synthesis was performed
as in (23). For PAR binding either anti-PAR immunos-
taining was performed or, as for DNA binding, mem-
branes were incubated for 1h at 48C with
32P
radiolabeled PAR or DNA, washed three times in PBS
and submitted to autoradiography. Far-western blotting
was done as described in (18).
Band shiftassay
Electrophoretic mobility shift assays (EMSAs) were car-
ried out to analyze primase binding with PhiX174-ssDNA
as previously described (24). Brieﬂy, 2mg of primase (p48/
p58) were incubated with 70ng PhiX174-ssDNA and
increasing amounts (0, 63, 127 and 255ng) of PAR in
binding buﬀer (ﬁnal concentration: 10mM Tris/HCl pH
7.5, 5mM EDTA, 50mM NaCl and 1mg Bovin Serum
Albumin (BSA)) at 258C for 30min. The protein–DNA
complexes were separated by 0.8% agarose gel electro-
phoresis with 60mA for 4h. The DNA was then stained
with ethidium bromide and ssDNA and protein–DNA
complexes were determined using a ﬂuoroimager FLA-
5100 and the software ImageGauge version 4.2.3 (Fuji
Europe, Du ¨ sseldorf, Germany).
Primase activity
One unit of DNA primase (p48–p58) was incubated with
0.1mM (nucleotide concentration) oligo (dT)20, 500mM
ATP and 10mCi [a
32P]ATP in a 10mM Tris Ac pH 7.3,
10mM MgAc, 1mM DTT and 0.1mg/ml BSA buﬀer.
After 15min at 378C, the reactions were spotted on
DE81 ﬁlters (Whatman). Filters were washed four times
in 0.4M ammonium bicarbonate, 1% PPi rinsed twice
in H2O, dried, and submitted to scintillation counting
in Ultima Gold scintillation liquid (Packard).
Cell cycle experiments
HeLa cells (10
6) grown in 10-cm Petri dish were transiently
transfected with the pBC or pBC-hXRCC1-fragments
vectors using JetPEI transfection reagent (Polyplus
Transfection). When indicated, cells were incubated for
30min at 378C with 1mM MNU (Sigma), washed and
grown in fresh culture medium for 20h. Cells were pulse
labeled for 30min at 378C in DMEM medium supplemen-
ted with 5mM BrdU (Sigma). After two PBS washes, cells
were detached by trypsination, washed in PBS buﬀer
Glucose EDTA (PGE) (PBS 1, 1g/l glucose, 1mM
EDTA) buﬀer and ﬁxed for 30min on ice in 70% EtOH
in PGE. Cells were centrifuged and incubated for 4h at
48C in 5ml PGE for rehydration. Cells were treated for
15min at room temperature in 2N HCl in PGE, collected
by centrifugation, and resuspended in 2ml neutralization
PBS buﬀer Sodium tetraborate Tween BSA (PTTB) buﬀer
(PBS 1, 0.5% Tween 20, 0.5% BSA, 0.1M sodium tetra-
borate) and washed twice in PTB buﬀer (PBS 1, 0.5%
Tween 20, 0.5% BSA). Cells were then incubated for 1h at
room temperature in mouse monoclonal anti-BrdU anti-
bodies (Becton Dickinson) diluted to 1:3 ratio and rabbit
polyclonal anti-GST antibodies (Sigma) diluted to 1:2000
ratio. After two washes in PTB buﬀer, cells were incubated
for 1h at room temperature in Alexa 488 conjugated goat
anti-mouse secondary antibodies (Invitrogen) at 1:500
ratio and PE conjugated donkey anti-rabbit secondary
antibodies (Jackson Immuno Research) at 1:200 ratio.
After two washes in PTB buﬀer, cells were counterstained
with 10mg/ml 7-aminoactinomycin-D (7-AAD, Sigma) in
PGE. Flow cytometry analysis was performed using a
FACS Calibur and the Cell Quest software (Becton
Dickinson).
Xenopusextracts andDNA replication assay
Sperm nucleus and egg extracts were prepared as
described previously (25). Upon thawing, extracts were
supplemented with cycloheximide (250mg/ml) and an
energy regeneration system (10mg/ml creatine kinase,
10mM creatine phosphate, 1mM ATP, 1mM MgCl2).
MMS treatment (either 50 or 75mM depending upon
egg extracts) of sperm nuclei was carried out as previously
described (26). When recombinant proteins were added,
these were incubated in egg extracts for 10min on ice
before addition of sperm chromatin. To follow DNA rep-
lication by incorporation of radiolabeled nucleotide
into newly replicated DNA, 1mlo fa-[
32P] dATP or
dCTP (3000Ci/mmol) was added to a standard reaction
of 50ml and the amount of newly synthesized DNA was
determined by TCA precipitation on GF/C glass ﬁbers
ﬁlters followed by scintillation counting. Ku-0058948
was used as PARP inhibitor (27). Alkaline gel electropho-
resis of DNAs and chromatin isolation were performed as
previously described in (28) and (29), respectively.
RESULTS
hXRCC1interactswiththep58subunitofDNAPola-primase
To identify new proteins interacting with the BRCT1
domain of hXRCC1, we used recombinant GST-tagged
hXRCC1 fragment (amino acids 282–428) to pull down
protein partners from HeLa cell extracts. Co-puriﬁed pro-
teins were separated by SDS–PAGE and analyzed by mass
spectrometry. The identiﬁcation of proteins already
known to interact with XRCC1 such as PARP-1, PCNA
and DNA-PKcs validated our analysis (5,14,18). In addi-
tion, we identiﬁed the p58 subunit of the DNA Pol
a-primase as a novel hXRCC1-BRCT1 interacting protein
(Figure 1A).
To test whether endogenous p58 and XRCC1 coexist
in a common protein complex, immunoprecipitation
experiments were performed using extracts from HeLa
cells treated or not with aphidicolin (A), with HU or
Nucleic Acids Research, 2009,Vol.37, No. 10 3179with both drugs to block DNA replication. As shown in
Figure 1B, p58 was weakly but reproducibly co-immuno-
precipitated with XRCC1, speciﬁcally after HU treatment.
These results suggest a preferential interaction between
XRCC1 and DNA primase when DNA replication forks
are stalled.
In order to map the p58 interaction domain(s) within
XRCC1, GST fusion proteins that encompass truncated
versions of human XRCC1 were generated (Figure 1C).
These fusion proteins were expressed in HeLa cells and
GST pull-down experiments were performed, followed
by western blot analysis. The endogenous p58 subunit eﬃ-
ciently co-puriﬁed with polypeptides carrying either the
N-terminal part of XRCC1 (amino acids 1–170) or the
BRCT1 domain but not the BRCT2 domain (Figure 1C).
To further characterize the interaction between XRCC1
and p58, we analyzed the localization of both endogenous
proteins by immunoﬂuorescence in asynchronous cells
treated or not with HU. No or very few XRCC1 and
p58 foci co-localized in untreated cells; whereas after
HU treatment, p58 and XRCC1 foci number increased
and signiﬁcant co-localization was observed between the
two proteins (Figure 1D).
Taken together, these results suggest that hXRCC1 and
DNA primase, via its p58 subunit, can associate in vivo in
response to stalled replication forks.
In vitro association of XRCC1 withp58-Nter
Far-western blot analyses were performed to assess
whether the interaction between p58 and hXRCC1 was
direct. The p48-His-tagged p58 complex and the N-
(amino acids 1–266) or C-terminal (amino acids
267–509) part of p58 were independently expressed in
E. coli, puriﬁed by aﬃnity chromatography and separated
by SDS–PAGE along with negative (tropomyosine, BSA)
and positive (PARP-1) controls. Proteins transferred to
PVDF membranes were re-naturated prior incubation
with puriﬁed hXRCC1 protein and immunodetected
with anti-XRCC1 antibody (Figure 2B). XRCC1 inter-
acted only with p58 and its N-terminus fragment,
p58
PCNA
PARP1
DNA-PKcs
GST-BRCT1
GSTdimer
GST
GST-BRCT1
GST A
WB: 1-170
170-428
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   –        A       HU   A+H U  –        A      HU   A+HU    –
WB
IP:
D DAPI Merge p58 XRCC1
–HU
+HU
GST
Figure 1. Interaction between XRCC1 and p58 subunit of Pol a-primase. (A) Identiﬁcation of proteins interacting with GST-XRCC1-BRCT1 by
mass spectrometry. Sypro ruby stained gel after GST pull-down of HeLa cell extracts expressing either GST or GST-hXRCC1-BRCT1 fused
proteins. (B) Identiﬁcation of XRCC1 associated p58 by immunoprecipitation of XRCC1 from extracts of HeLa cells treated or not with aphidicolin
(A: 5mg/ml, 16h) and with or without HU (4mM, 4h). Co-purifying p58 and immunoprecipitated XRCC1 were identiﬁed by western blot. Inputs
represent 5% of the total proteins used in immunoprecipitation (pi: pre immune serum). (C) GST pull-down of p58 with diﬀerent GST-fused XRCC1
domains overexpressed in HeLa cells. A schematic drawing of XRCC1 domain structure is shown. (D) Indirect immunoﬂuorescence microscopy
showing co-localization of XRCC1 and p58 in HeLa cells treated (+HU) or not (HU) with 4mM HU for 4h.
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These results demonstrated a direct contact between
XRCC1 and the N-terminus domain of p58.
PAR binds p58 and strongly inhibits DNA primase activity
of thep48–p58complex
Since XRCC1-BRCT1 has strong aﬃnity for PAR, we
investigated whether p58 could also bind PAR. A search
for putative PAR binding motifs in the sequence of p48
and p58 identiﬁed two potential PAR binding sites in p58,
one in the N-terminal part (amino acids 101–111) and one
in the C-terminal part (amino acids 286–296) of the pro-
tein. To determine whether these sites were functional,
binding of DNA primase to PAR was ﬁrst analyzed by
dot blot. As expected, PAR bound to PARP-1, XRCC1
and the BRCT1 domain of XRCC1 but not to the BRCT2
domain of XRCC1 or to GST. Under the same conditions,
the p48–p58 complex interacted with PAR (Figure 3A).
To identify precisely the domain of the DNA primase
responsible for PAR binding, we separated the p48–p58
subunits along with the N-terminal (amino acids 1–266)
and C-terminal (amino acids 266–509) part of p58 by
SDS–PAGE and analyzed by radiolabeled PAR binding
on proteins blotted on membrane. Results showed that
PAR only bound to the N-terminal fragment of p58
(Figure 3B).
Next, we wanted to determine whether PAR binding
could aﬀect the ability of primase to bind DNA. Puriﬁed
p48–p58 DNA primase (1 and 2mg) was dotted on nitro-
cellulose and incubated successively with oligo(dT)20 and
radioactively labeled PAR. PAR was able to bind to
p48–p58 in the absence of pre-incubation with DNA;
whereas, incubation with unlabeled oligo(dT)20 prior to
PAR addition dramatically decreased the eﬃciency of
PAR binding (Figure 3C). When the membranes were
ﬁrst incubated with radioactively labeled DNA
oligo(dT)20 and then with increasing concentrations of
unlabeled PAR, we observed a decrease in the intensity
of the radioactive signal retained onto the membrane indi-
cating that the PAR can dislodge DNA from p48–p58
complex (Figure 3C). This observation was conﬁrmed by
band-shift assays performed with puriﬁed recombinant
p48–p58 and single-stranded DNA. Adding increasing
concentrations of PAR (PAR/DNA ratio: 0, 1–4) to the
reaction strongly decreased the binding of p48–p58 to
DNA (Figure 3D).
To evaluate the eﬀect of PAR on primase activity, we
monitored the incorporation of radiolabeled ribonucleo-
tide on an oligo(dT)20 DNA substrate in the presence of
increasing PAR concentrations. Low PAR/template DNA
ratio had no eﬀect on primase activity; whereas, equimolar
conditions of PAR and DNA in the reaction strongly
inhibited the radioactive nucleotide incorporation
(Figure 3E). Altogether these results indicate that
PAR competes with DNA for p58 binding to inhibit
DNA primase activity.
XRCC1-BRCT1 stimulates PARP-1 activity andis
poly(ADP-ribosyl)ated in responseto DNA damage
The fact that PAR aﬀects primase activity and
hXRCC1-BRCT1 interacts with p58 prompted us to
examine whether hXRCC1-BRCT1 could be poly(ADP-
ribosyl)ated in vivo. GST-tagged hXRCC1-BRCT1 over-
expressed in undamaged HeLa cells was slightly
poly(ADP-ribosyl)ated, in contrast to GST alone or
GST-hXRCC1-BRCT2 which were not poly(ADP-rybo-
syl)ated (Figure 4B, compare lane 1 with lanes 4 and 7).
Treatment of cells with 2.5mM MMS for 30min triggered
PARP-1 activation and PAR synthesis, and cells overex-
pressing GST-hXRCC1-BRCT1 displayed high levels of
automodiﬁed PARP-1 suggesting that hXRCC1-BRCT1
overexpression stimulates PARP-1 activity (Figure 4B,
lanes 2, 5 and 8). In addition, GST-hXRCC1-BRCT1
was poly(ADP-ribosyl)ated in MMS-treated cells and
this modiﬁcation decreased in the presence of the PARP
inhibitor Ku-0058948 (Figure 4B, lanes 2 and 3). The sig-
nals recognized by the PAR antibody with a molecular
weight higher than 116kDa, co-purifying with GST-
hXRCC1-BRCT1 correspond to automodiﬁed PARP-1
which strongly interacts with the BRCT1 domain of
XRCC1 (5). The observation that GST-hXRCC1-
BRCT1 is poly(ADP-ribosyl)ated in vivo conﬁrmed pre-
vious in vitro data showing that this domain could be
covalently poly(ADP-ribosyl)ated by PARP-1 (and
PARP-2) in addition to its non-covalent binding to PAR
(6). The increased PAR level observed in undamaged
GST-hXRCC1-BRCT1 expressing cells was conﬁrmed
by immunoﬂuorescence microscopy. PAR synthesis was
detected in HeLa cells overexpressing GFP-hXRCC1-
BRCT1 but not GFP-hXRCC1-BRCT2 (Supplementary
Figure 1). Treatment of cells with hydrogen peroxide trig-
gered higher amount of PAR produced in GFP-hXRCC1-
BRCT1 expressing cells compared to untransfected or
GFP-hXRCC1-BRCT2 expressing cells (Supplementary
Figure 1). In addition, some PAR foci colocalized with
GFP-hBRCT1 but not with GFP-hBRCT2.
BSA
PARP-1
p48-p58
p58-Nter
Tropomyosin
p58-Cter
kDa
150
100
75
50
37
25
Overlay of XRCC1 and
anti-XRCC1 Immunostaining 
p58
p58-
Nter
p48
BSA
PARP-1
p48-p58
p58-Nter
Tropomyosin
p58-Cter
Amido black staining
AB
Figure 2. In vitro association of XRCC1 with the N-terminal domain of
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in E. coli were separated by SDS–PAGE and transferred onto a nitro-
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and Nasheuer, unpublished data).
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of hXRCC1-BRCT1 domain in HeLa cells stimulates
PAR synthesis in damaged cells which leads to its
poly(ADP-ribosyl)ation.
XRCC1-BRCT1 overexpressing cells accumulate inSphase
following DNA damage
The poly(ADP-ribosyl)ation of hXRCC1-BRCT1 in
response to DNA damage, the interaction of p58 with
PAR and hXRCC1-BRCT1 and the inhibition of DNA
primase activity by PAR lead us to hypothesize that the
overexpression of the BRCT1 domain of XRCC1 would
have the potential to halt DNA replication of damaged
DNA.
To test this possibility, truncated fragments of hXRCC1
fused to GST were overexpressed in HeLa cells and the
progression through the cell cycle was analyzed by ﬂow
cytometry (FACS). The cell cycle of untreated transfected
cells was not aﬀected by the overexpression of any of the
hXRCC1 fusion proteins (Figure 5A). In contrast, 20h
following treatment with the alkylating agent methyl
nitrosourea (MNU), cells expressing hXRCC1 fragments
containing the BRCT1 domain (amino acids 170–428,
282–428 and 314–428) showed a strong accumulation in
S phase leading to a decreased G2/M phase (Figure 5A).
Quantiﬁcation of the DNA synthesis was performed by
monitoring BrdU incorporation in cells overexpressing
either the hBRCT1 (amino acids 282–428) fused to GST
or GST alone, 20h after treatment with 1mM MNU
(Figure 5B). MNU treatment lead to an increased
number of BrdU positive cells that was higher for GST-
hXRCC1-BRCT1 than GST overexpression (25% versus
15.5%, respectively, Figure 5B). However, HeLa cells
expressing GST were evenly distributed throughout
the S phase; whereas, GST-hXRCC1-BRCT1-expressing
cells were enriched in the early S phase just after the
G1 exit.
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expression of the BRCT1 domain of hXRCC1 leads to a
strong accumulation of MNU-treated human cells in early
S phase. This eﬀect is speciﬁc for the BRCT1 domain,
since overexpression of GST-hBRCT2 had no particular
eﬀect on cell cycle progression whether the cells were trea-
ted with alkylating agents (Figure 5A and data not
shown).
XRCC1-BRTC1 slows down DNA synthesis in Xenopus
egg extracts
To gain further insight into the biological signiﬁcance of
the interaction between XRCC1, PAR and the p58 sub-
unit of Pol a-primase during the replication of damaged
DNA, we used Xenopus laevis egg extracts. The cell-free
aspect of this system allows the detailed analysis at the
molecular level of the diﬀerent steps of DNA synthesis
and its biochemical manipulation, by the addition of
either puriﬁed proteins to assess for a dominant eﬀect or
pharmacological drugs to inhibit speciﬁc activities.
Introduction of Xenopus sperm chromatin in such extracts
results in the assembly of a nuclear membrane around
DNA and the execution of a single complete round of
semiconservative replication (30). To this end, sperm chro-
matin treated or not with MMS (‘Materials and Methods’
Section) was introduced into egg extracts synchronized in
early S phase and DNA replication was monitored by
following the incorporation of a radiolabeled nucleotide
precursor. Either GST or GST-xXRCC1-BRCT1 (amino
acids 307–414 from X. laevis XRCC1) was added to egg
extracts prior to the initiation of DNA synthesis.
As shown in Figure 6A, replication of sperm chromatin
treated with low concentrations of MMS was slightly
impeded in extracts supplemented with GST as con-
trol (85% of replication compared to the 100% in
the untreated reaction), conﬁrming that replication of
alkylated DNA is slowed down in this system (31).
Consistent with what was observed in HeLa cells
(Figure 5), replication of MMS-treated chromatin was
strongly slowed down when egg extracts were supplemen-
ted with GST-xXRCC1-BRCT1 (>40% reduction of
replication, Figure 6A). To further characterize the
defect in DNA synthesis induced by the xXRCC1-
BRCT1 domain, replication intermediates were analyzed
by alkaline gel electrophoresis. In this assay, nascent DNA
is detected as a smear corresponding to growing DNA
chains, while fully replicated DNA is visible as high
molecular weight species. As expected, nascent DNA
accumulated in the presence of MMS compared to the
mocked-treated reaction (Figure 6B, compare right to
left panel), which is due to a delay in ongoing DNA
synthesis. Upon MMS treatment, the addition of GST-
xXRCC1-BRCT1 resulted in a much stronger accumula-
tion of nascent DNA compared to the GST control
(Figure 6B, right panel). After 100min of incubation in
the presence of GST-XRCC1-BRCT1, very little fully
replicated DNA was synthesized, while by this time the
replication of mock-treated chromatin was complete.
Moreover, the abundance of early replication inter-
mediates (within 40min) decreased in the presence of
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initiation and elongation steps of DNA synthesis.
We examined whether PAR production could be
observed on MMS-treated sperm chromatin in Xenopus
extracts supplemented with GST-xXRCC1-BRCT1.
Indeed, PAR production, which was detectable in nuclei
treated with MMS, was dramatically increased by the
addition of GST-xXRCC1-BRCT1 (data not shown) as
observed in HeLa cells. Owing to the inhibitory eﬀect of
PAR on primase activity, we hypothesized that the mas-
sive PAR production caused by the presence of GST-
xXRCC1-BRCT1 could be responsible for the inhibition
of replication and that this eﬀect could be reversed by
addition of a PARP inhibitor. Results shown in
Figure 6C conﬁrmed this hypothesis, since pre-incubation
of Xenopus extracts with the PARP inhibitor rescued the
DNA synthesis delay induced by the addition of GST-
xXRCC1-BRCT1, whereas this inhibitor had no eﬀect
on replication of MMS-treated chromatin in the presence
of GST (Supplementary Figure 2A). Taken together, these
results conﬁrm that the BRCT1 domain of XRCC1 inhi-
bits replication of damaged DNA in Xenopus egg extracts.
XRCC1-BRTC1 binds to chromatin andinterferes with
formationof functionalreplication forks
To characterize in more detail the DNA synthesis defect
induced by xXRCC1-BRCT1 in the presence of DNA
damage, we analyzed the recruitment to chromatin of rep-
lication factors speciﬁc of the diﬀerent steps of DNA
synthesis. Hence, sperm chromatin was exposed to MMS
and incubated in egg extracts supplemented with the indi-
cated proteins, as described in Figure 6A. Chromatin frac-
tions were analyzed by western blot for the binding of the
indicated proteins. The GST-xXRCC1-BRCT1 domain
bound Xenopus chromatin, and its chromatin association
was enhanced by MMS treatment (Figure 6D). Addition
of the xXRCC1-BRCT1 domain did not induce phosphor-
ylation of the Chk1 protein kinase in the absence
of MMS, demonstrating that the inhibition of DNA
synthesis observed when xXRCC1-BRCT1 is added to
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tion of the DNA damage checkpoint (Supplementary
Figure 2B). The chromatin binding of ORC1, a subunit
of the ORC essential for the assembly of preRCs, and that
of RPA32, a component of pre-ICs that binds to single
stranded DNA at replication forks, were not signiﬁcantly
aﬀected by the addition of GST-xXRCC1-BRCT1, indi-
cating that pre-RCs and pre-ICs assembled normally.
Consistent with this conclusion, the chromatin binding
of the pre-RC component MCM2 was not aﬀected,
but even it increased following addition of GST-
xXRCC1-BRCT1. In contrast, PCNA binding to MMS-
treated sperm chromatin was abolished in the presence of
GST-xXRCC1-BRCT1 (Figure 6D), while this inhibition
was signiﬁcantly rescued in the presence of PARP inhibi-
tor (Supplementary Figure 2C).
Since PCNA requires the activity of DNA Pol a-pri-
mase to bind to chromatin and stimulates replication elon-
gation (32,33), these results strongly argue that the
BRCT1 domain of xXRCC1, by interfering with the activ-
ity of DNA Pol a -primase, regulates the progression of
replication forks through damaged DNA.
DISCUSSION
Several reports have put forward the idea that XRCC1
could play a role in the control of replication fork pro-
gression when DNA is damaged. The ﬁrst indication came
from the observation that XRCC1 deﬁcient EM9 cells dis-
play high levels of SCEs, reﬂecting the accumulation of
unrepaired SSB converted to DBS at collapsed replication
forks (2). Kubota and Horiuchi (4) showed that comple-
mentation of EM9 cells with XRCC1 point mutated in the
BRCT1 domain could not restore nascent DNA replica-
tion after MMS treatment. While the BRCT2 domain of
XRCC1 is only required for BER/SSBR during G1, the
BRCT1 domain was shown to be critical for eﬃcient
repair during G1 but also S/G2 phase of the cell cycle
(3). More recently, Brem and Hall (34) found that low-
ering XRCC1 levels by RNA interference led to a signif-
icant delay in S-phase progression after exposure to MMS.
XRCC1 was shown to interact with PCNA and both
proteins displayed co-localization during S phase of unda-
maged cells (14). In addition, Parlanti et al. (35) demon-
strated the existence of a multiprotein complex containing
the DNA replicative polymerases Pol a-d-e the replication
protein MCM7, BER/SSBR components including
XRCC1 and Pol b and the cell cycle regulatory protein
cyclin A. They proposed that XRCC1 could act as an
early eﬀector of cellular response to DNA breaks at stalled
replication. All these studies clearly identiﬁed XRCC1 as a
critical factor acting when replication forks encounter
damaged DNA. The idea most commonly advanced was
that BER/SSBR machineries are associated to the replica-
tion machinery in order to coordinate the repair of DNA
lesions with replication fork progression, thus avoiding
the conversion of unrepaired damaged bases or single-
strand breaks to mutations or highly toxic DSBs during
replication. However, the precise role of XRCC1 in this
process remained an open question.
In this study, we identiﬁed the p58 subunit of the Pol
a-primase complex as a novel important element that links
XRCC1 to the replication apparatus. We demonstrate an
interaction between the BRCT1 domain of XRCC1 and
the N-terminal part of the p58 and observed co-localiza-
tion between XRCC1 and p58 in damaged cell nuclei. In
addition, we found that the N-terminal domain of p58
bound PAR, leading to inhibition of primase activity.
XRCC1-BRCT1 domain overexpressed in HeLa cells is
poly(ADP-ribosyl)ated following DNA damage and led
to the accumulation of MNU-treated HeLa cells in early
S phase. The inhibition of replication of damaged DNA
was also observed in Xenopus egg extracts, suggesting that
this regulation is conserved in vertebrates. Looking more
deeply into the molecular mechanism, we found that in the
presence of DNA damage, the BRCT1 domain of Xenopus
XRCC1 did not interfere with the formation of both pre-
RCs and pre-ICs, but strongly inhibited the association of
PCNA with replicating chromatin. Thus, our results sug-
gest that overexpression of XRCC1-BRCT1 could inter-
fere either with SSBR, as a dominant negative factor, or
with the establishment of functional replication forks and/
or ongoing DNA synthesis. But the observed interaction
of XRCC1-BRCT1 with p58, the distribution of cells in S
phase in HeLa XRCC1-BRCT1 and the inhibition of
chromatin association of PCNA with MMS-treated chro-
matin lead us to preferentially propose a role for XRCC1
in the coordination of DNA repair and replication during
S phase.
The inhibition of p58 primase activity by PAR in the
presence of damaged DNA is strikingly reminiscent of the
mechanism recently described in Bacillus subtilis by which
guanosine penta- and tetraphosphate [(p)ppGpp] were
synthetized by RelA in response to nutritional stress,
directly inhibits primase activity to stop ongoing DNA
replication (36). It was proposed that this regulation
might avoid replication fork collapse during nutrient dep-
rivation and therefore maintain genome integrity. In
eukaryotes, PAR may play a similar role in response to
DNA damage during S phase. The implication of PARP-1
and poly(ADP-ribosyl)ation in the replication arrest in
response to DNA damage has been previously documen-
ted. PARP-1 activity was shown to inhibit the replicative
polymerase activities of DNA Pol a and -d and the DNA
repair polymerase activity of Pol b in vitro (37,38). We
and others previously reported the physical interaction
between PARP-1 and the 180kDa catalytic subunit of
DNA Pol a-primase, as well as the impaired S-phase
DNA synthesis in PARP-1-deﬁcient or depleted mouse
embryonic ﬁbroblasts (39,40). In contrast, our experi-
ments presented here reveal that HeLa cells overexpres-
sing GST-hXRCC1-BRCT1 displayed an increased PAR
synthesis under damage conditions and cells accumulated
in the early S phase. In addition, the delayed replication of
MMS-treated chromatin from Xenopus egg extracts upon
addition of GST-xXRCC1-BRCT1 was alleviated in the
presence of a PARP inhibitor, thus highlighting the role of
PAR in the replication arrest of damaged chromatin.
The inhibition of primase activity in vitro by PAR that
competes with template DNA points to a critical
step subjected to regulation by poly(ADP-ribosyl)ation.
3186 Nucleic Acids Research, 2009, Vol. 37,No. 10Our results shed light onto previous observations by
Yoshihara et al. (38) who reported that PARP-1, in the
presence of NAD
+, could inhibit, in vitro, the DNA Pol a
and the primase activities, which are restored by a PARP
inhibitor, suggesting that both the primase and polymer-
ase are directly controlled by PAR. Very recently, PARP-1
was also shown to slow down fork progression in response
to damage induced by the topoisomerase I inhibitor camp-
tothecin (41).
This points out the need of an appropriate PAR bearing
protein, such as XRCC1 through its BRCT1 domain, and
suggests that poly(ADP-ribosyl)ated XRCC1 could be a
factor that targets p58 to inhibit replication on a damaged
template.
Interaction between XRCC1 and primase could also
help to stabilize stalled replication forks preventing them
from collapsing. Subsequently, degradation of PAR could
help to stabilize the replication machinery and promotes
its reactivation. This hypothesis refers to the work of
Maruta et al. (42) who proposed that PAR degradation
by PARG could be a source of ATP required for repli-
some stability. If replication fork arrest fails when a SSB is
present and leads to the generation of a DSB, then the
activation of double-strand end-joining repair will be
turned on by another function of XRCC1, through its
interaction and stimulation of the NHEJ factor DNA-
PK (18). In a recent paper, Brem et al. showed that unre-
solved BER intermediates give rise to lesions activating
both ATM and ATR and leading to S-phase delay. This
delay is required to repair damages through a recombina-
tional repair pathway involving Rad51 (43).
These ﬁndings raise the question about the relevance
of the XRCC1-PAR-p58 interaction. Inhibiting primase
activity by PAR, which is facilitated by the interactions
of XRCC1 with p58 and PARP-1, may give cells more
time to repair DNA lesions prior to resume the replication
process and thus avoid conversion of SSBs into DSBs. A
role for DNA primase, delaying the progression of repli-
cation when DNA needs ﬁrst to be mended, is consistent
with its role as a molecular brake in DNA replication
when leading strand synthesis is prevented from outspa-
cing lagging strand synthesis, as reported for bacteria and
T7 bacteriophage DNA replication (44,45). As the Pol
a-primase complex is required for both the initiation of
DNA replication and the lagging strand DNA synthesis, it
is therefore a likely target for coupling DNA replication to
the DNA damage response (46).
We propose that XRCC1 plays a central role in
the coordination of DNA repair and replication during
S phase. In response to DNA damage, poly(ADP-ribosyl)-
ated XRCC1 slows down replication via its functional
interaction with the p58 subunit of the Pol a-primase
complex in order to allow damage repair to take place
or acting, if necessary, as a molecular switch between
SSBR and Double Strand Break Repair (DSBR).
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